Atlas Trials

Microcirculation Recruitment Using Albumin 20% and Terlipressin in Septic Patients

Clinical trial NCT05080543 · UNKNOWN

Trial details

NCT number
NCT05080543
Sponsor
Amany Mousa Salama Muhammed
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Septic Shock
Start date
2021-10-01
Primary completion
2022-09-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.